期刊文献+
共找到8篇文章
< 1 >
每页显示 20 50 100
甲状腺乳头状癌中PPM1D的表达和意义 被引量:2
1
作者 任伟民 张友元 +2 位作者 罗金芳 叶宣光 董军明 《临床与实验病理学杂志》 CAS CSCD 北大核心 2012年第6期623-626,共4页
目的探讨甲状腺乳头状癌(papillary carcinoma of thyroid,PTC)中PPM1D蛋白的表达情况及其与临床病理特征和p53的关系。方法应用免疫组化EnVision法检测55例PTC及癌旁正常组织中PPM1D蛋白的表达情况并进行统计处理,分析其与临床病理特... 目的探讨甲状腺乳头状癌(papillary carcinoma of thyroid,PTC)中PPM1D蛋白的表达情况及其与临床病理特征和p53的关系。方法应用免疫组化EnVision法检测55例PTC及癌旁正常组织中PPM1D蛋白的表达情况并进行统计处理,分析其与临床病理特征的关系及和p53蛋白表达的相关性。结果 55例PTC中PPM1D的表达(74.5%,41/55)高于癌旁正常组织(10.9%,6/55),差异有统计学意义;PPPM1D的表达与患者年龄、性别、肿瘤大小、组织学类型、淋巴结转移、TNM分期无关,而在间质硬化的病例中表达增强(P<0.05);PTC中PPM1D与p53蛋白表达呈负相关(r=-0.339,P<0.05)。结论高表达的PPM1D与PTC相关,与p53之间可能存在相互作用,在PTC发生、发展中具有重要意义。 展开更多
关键词 甲状腺肿瘤 乳头状癌 ppm1d P53 免疫组织化学
下载PDF
PPM1D mRNA表达与肝癌预后的相关性研究 被引量:1
2
作者 袁莉 刘军 李光兵 《中国现代普通外科进展》 CAS 2016年第4期263-266,270,共5页
目的 :探讨PPM1D m RNA表达与肝癌预后的相关性。方法:提取86例肝癌患者癌组织及癌旁肝组织总RNA,q PCR法检测PPM1D m RNA表达量,免疫组化检测蛋白表达水平。根据癌旁肝组织中PPM1D m RNA表达量,将肝癌患者分组为高表达组与低表达组,对... 目的 :探讨PPM1D m RNA表达与肝癌预后的相关性。方法:提取86例肝癌患者癌组织及癌旁肝组织总RNA,q PCR法检测PPM1D m RNA表达量,免疫组化检测蛋白表达水平。根据癌旁肝组织中PPM1D m RNA表达量,将肝癌患者分组为高表达组与低表达组,对两组患者临床资料及生存时间进行统计分析。结果:PPM1D m RNA在肝癌组织中表达水平显著高于癌旁组织,免疫组化检测蛋白表达水平证实上述结果。以癌旁肝组织PPM1D m RNA表达量为阈值,高表达组56例,低表达组30例。两组患者的AFP水平、肿瘤大小、肿瘤TNM分期以及肿瘤复发、家族史等临床病理因素差异有统计学意义(P<0.01);年龄、性别、门静脉侵犯、淋巴结转移、HBV感染及酒精摄入史等因素差异无统计学意义(P>0.05)。高表达组患者中位生存期为13个月,低表达组为32个月。结论:PPM1D m RNA表达水平可能与肝癌恶性程度相关,可能成为肝癌预后的预测因子。 展开更多
关键词 肝肿瘤 ppm1d MRNA 预后
下载PDF
PPM1D Silencing by Lentiviral-mediated RNA Interference Inhibits Proliferation and Invasion of Human Glioma Cells 被引量:3
3
作者 王鹏 饶竞 +2 位作者 杨海峰 赵洪洋 杨林 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2011年第1期94-99,共6页
To construct a lentiviral shRNA vector targeting human protein phosphatase 1D magnesium-dependent(PPM1D) gene and detect its effectiveness of gene silencing in human gliomas,specific siRNA targets with short hairpin... To construct a lentiviral shRNA vector targeting human protein phosphatase 1D magnesium-dependent(PPM1D) gene and detect its effectiveness of gene silencing in human gliomas,specific siRNA targets with short hairpin frame were designed and synthesized.DNA oligo was cloned into the pFU-GW-iRNA lentiviral expression vector,and then PCR and sequencing analyses were conducted to verify the constructs.After the verified plasmids were transfected into 293T cells,the lentivirus was produced and the titer of virus was determined.Real-time quantitative PCR and Western blot were performed to detect the PPM1D expression level in the infected glioma cells.PCR and Western blot analyses revealed the optimal interfering target,and the virus with a titer of 6×10^8 TU/mL was successfully packaged.The PPM1D expression in human glioma cells was knocked down at both mRNA and protein levels by virus infection.The expression of PPM1D mRNA and protein was decreased by 76.3% and 87.0% respectively as compared with control group.The multiple functions of human glioma cells after PPM1D RNA interference were detected by flow cytometry and cell counting kit-8(CCK-8).Efficient down-regulation of PPM1D resulted in significantly increased cell apoptosis and reduced cell proliferation and invasion potential in U87-MG cells.We have successfully constructed the lentiviral shRNA expression vector capable of stable PPM1D gene silencing at both mRNA and protein levels in glioma cells.And our data gave evidence that the reduced cell growth observed after PPM1D silencing in glioma cells was at least partly due to increased apoptotic cell death. 展开更多
关键词 ppm1d GLIOMA RNA interference LENTIVIRUS apoptosis
下载PDF
PPM1D基因突变致Jansen-de Vries综合征一例并文献复习
4
作者 连子硕 张晓莉 +2 位作者 李肖 郭芪良 贾天明 《癫痫杂志》 2024年第4期353-359,共7页
Jansen-de Vries综合征又称为“具有胃肠功能紊乱和高疼痛阈值的智力发育障碍”(Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold,IDDGIP)[(OMIM):617450],是一种由PPM1D基因突变导... Jansen-de Vries综合征又称为“具有胃肠功能紊乱和高疼痛阈值的智力发育障碍”(Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold,IDDGIP)[(OMIM):617450],是一种由PPM1D基因突变导致多系统受累的常染色体显性遗传(Autosomal dominant,AD)或常染色体隐性遗传(Autosomal recessive,AR)的罕见疾病. 展开更多
关键词 Jansen-de Vries综合征 ppm1d基因 智力障碍 基因突变 癫痫
原文传递
PPM1D基因突变致Jansen-de Vries综合征临床表型与基因型特点分析 被引量:3
5
作者 梅道启 王媛 +6 位作者 陈国洪 梅世月 杨秀安 郝新征 李艳娜 王潇娜 张耀东 《中华神经科杂志》 CAS CSCD 北大核心 2021年第11期1140-1147,共8页
目的探讨1例Jansen-de Vries综合征患儿的临床表型,明确其基因诊断及遗传学特点,提高临床上对本病的认识。方法收集郑州大学附属儿童医院2019年10月确诊的1例Jansen-de Vries综合征患儿的临床资料,采用核心家系全外显子基因组检测(Trio-... 目的探讨1例Jansen-de Vries综合征患儿的临床表型,明确其基因诊断及遗传学特点,提高临床上对本病的认识。方法收集郑州大学附属儿童医院2019年10月确诊的1例Jansen-de Vries综合征患儿的临床资料,采用核心家系全外显子基因组检测(Trio-WES)及染色体拷贝数变异(CNV)分析技术,对患儿及其父母进行基因检测,采用一代Sanger测序法对发现可能存在的致病突变进行家系成员验证,并进行临床和分子遗传学分析。结合PPM1D基因突变智力障碍患者的相关报道进行文献复习。结果先证者女童,11个月,临床表现为智力障碍,语言及运动发育落后,自闭行为,胃肠功能障碍,身材矮小;鼻梁低平,低位耳,短指综合征。患儿核心家系Trio-WES结果提示:PPM1D基因新生移码杂合突变PPM1D(NM-003620):c.1216delA(p.Thr406Profs*3),染色体核型及染色体CNV分析正常。文献检索目前共报道有18例PPM1D基因突变的智力障碍患者,在在线人类孟德尔遗传数据库中描述为智力发育障碍伴胃肠道功能紊乱和痛觉阈值升高,其年龄分布在7个月至21岁,临床表现为智力障碍、疼痛阈值增高、行为异常、喂养困难、视力障碍、短指综合征、身材矮小、发热或呕吐及先天性发育畸形等相关的一组综合征。结论Jansen-de Vries综合征临床主要表现为全面性发育迟缓(智力障碍/运动发育迟缓、语言发育落后、肌张力低下),行为异常(孤独样行为、自闭症),颅面发育畸形(前额宽阔、鼻梁低平、低位耳、上唇薄),短指综合征(短脚、小手指粗短),胃肠功能紊乱(溢奶、喂养困难、便秘)。患儿诊断为PPM1D基因新发移码杂合突变变异,目前的治疗方式以康复训练为主,部分矮小症可予生长激素替代治疗,PPM1D基因[PPM1D(NM-003620):c.1216delA(p.Thr406Profs*3)]是该患儿的遗传学病因。 展开更多
关键词 Jansen-de Vries综合征 ppm1d基因 高疼痛阈值 智力低下 变异
原文传递
miR-16-5p enhances sensitivity to RG7388 through targeting PPM1D expression(WIP1)in Childhood Acute Lymphoblastic Leukemia 被引量:1
6
作者 Maryam Zanjirband Soheila Rahgozar Narges Aberuyi 《Cancer Drug Resistance》 2023年第2期242-256,共15页
Aim:Given the encouraging results of the p53-Mdm2 inhibitor RG7388 in clinical trials and the vital function of miR-16-5p in suppressing cell proliferation,the aim of the present study was to investigate the combined ... Aim:Given the encouraging results of the p53-Mdm2 inhibitor RG7388 in clinical trials and the vital function of miR-16-5p in suppressing cell proliferation,the aim of the present study was to investigate the combined impact of RG7388 and miR-16-5p overexpression on the childhood acute lymphoblastic leukemia(chALL).Methods:miRTarBase and miRDB,along with KEGG and STRING databases,were used to predict miR-16-5p target genes and explore protein-protein interaction networks,respectively.B-and T-lymphoblastic cell lines,in addition to patient primary cells,were treated with RG7388.Ectopic overexpression of miR-16-5p in Nalm6 cell line was induced through cell electroporation and transfection of microRNA mimics was confirmed by qRT-PCR.Cell viability was evaluated using the MTT assay.Western blot analyses were performed to evaluate the effects of RG7388 and miR-16-5p upregulation on the protein levels of p53 and its downstream target genes in chALL cells.Paired sample t-test was employed for statistical analyses.Results:MTT assay showed RG7388-induced cytotoxicity in wild-type p53 Nalm6 cell line and p53 functional patient primary cells.However,CCRF-CEM and p53 non-functional leukemic cells indicated drug resistance.Western blot analyses validated the bioinformatics results,confirming the downregulation of WIP1,p53 stabilization,as well as overexpression of p21WAF1 and Mdm2 proteins in Nalm6 cells transfected with miR-16-5p.Moreover,enhanced sensitivity to RG7388 was observed in the transfected cells.Conclusion:This is the first study indicating the mechanistic importance of miR-16-5p overexpression in chALL and its inhibitory role in leukemia treatment when combined with the p53-Mdm2 antagonist,RG7388.These findings might be useful for researchers and clinicians to pave the way for better management of chALL. 展开更多
关键词 Pediatric ALL miR-16-5p RG7388 ppm1d P53
原文传递
miR-6838-5p抑制卵巢癌细胞增殖和迁移的分子机制研究
7
作者 胡翠芳 陈梦雨 +2 位作者 黄寅虎 王婧 邱英 《山西医科大学学报》 CAS 2020年第12期1315-1320,共6页
目的分析微小RNA(miRNA,miR)-6838-5p在卵巢癌组织中的表达,探讨miR-6838-5p是否通过靶向PPM1D抑制卵巢癌细胞的增殖和迁移。方法选取2018年3月至2019年11月本院39例卵巢癌组织及癌旁组织,实时荧光定量PCR(qRT-PCR)法检测组织中miR-6838... 目的分析微小RNA(miRNA,miR)-6838-5p在卵巢癌组织中的表达,探讨miR-6838-5p是否通过靶向PPM1D抑制卵巢癌细胞的增殖和迁移。方法选取2018年3月至2019年11月本院39例卵巢癌组织及癌旁组织,实时荧光定量PCR(qRT-PCR)法检测组织中miR-6838-5p的表达水平。分别检测5种卵巢癌细胞株(OC3、SKOV-3、OVCAR-3、A2780、HO-8910)及正常卵巢上皮细胞(IOSE80)中miR-6838-5p的表达。选择miR-6838-5p表达水平最低的细胞株为对象,分为阴性对照组(转染NC模拟物)和miR-6838-5p组(转染miR-6838-5p模拟物)。细胞计数试剂盒(cell counting kit-8,CCK-8)和Transwell迁移实验分别检测各组细胞增殖和迁移能力。生物信息学技术和双荧光素酶报告基因实验分别预测和验证miR-6838-5p的靶基因。qRT-PCR和蛋白质印迹法(Western blot)检测各组细胞靶基因表达水平。结果miR-6838-5p在卵巢癌组织中相对表达水平低于癌旁组织,差异有统计学意义(P<0.01)。与正常卵巢上皮细胞相比,miR-6838-5p的表达水平在各卵巢癌细胞株降低(P<0.05),其中在OVCAR-3细胞中的表达最低(P<0.01)。过表达miR-6838-5p后,OVCAR-3细胞增殖能力在第2,3,4,5天低于阴性对照(P<0.05),OVCAR-3细胞迁移能力低于阴性对照(P<0.01)。生物信息学技术结合双荧光素酶报告基因实验显示miR-6838-5p的靶基因是PPM1D。过表达miR-6838-5p后,OVCAR-3细胞中PPM1D基因表达水平降低(P<0.01)。结论miR-6838-5p在卵巢癌组织和细胞株中的表达水平降低。miR-6838-5p可能通过靶向调控PPM1D基因的表达,抑制OVCAR-3细胞的增殖和迁移。 展开更多
关键词 miR-6838-5p 卵巢癌 ppm1d 细胞增殖 细胞迁移
下载PDF
Protein phosphatase magnesium-dependent 1δ is a novel tumor marker and target in hepatocellular carcinoma 被引量:3
8
作者 Zhi Xu Chunxiang Cao +11 位作者 Haiyan Xia Shujing Shi Lingzhi Hong Xiaowei Wei Dongying Gu Jianmin Bian Zijun Liu Wenbin Huang Yixin Zhang Song He Nikki Pui-Yue Lee Jinfei Chen 《Frontiers of Medicine》 SCIE CAS CSCD 2016年第1期52-60,共9页
Hepatocellular carcinoma (HCC) is a lethal liver malignancy worldwide. In this study, we reported that protein phosphatase magnesium-dependent 16 (PPM1D) was highly expressed in the majority of HCC cases (approxi... Hepatocellular carcinoma (HCC) is a lethal liver malignancy worldwide. In this study, we reported that protein phosphatase magnesium-dependent 16 (PPM1D) was highly expressed in the majority of HCC cases (approximately 59%) and significantly associated with high serum a-fetoprotein (AFP) level (P = 0.044). Kaplan- Meier and Cox regression data indicated that PPM1D overexpression was an independent predictor of HCC- specific overall survival (HR, 2.799; 95% CI, 1.346-5.818, P = 0.006). Overexpressing PPM1D promoted cell viability and invasion, whereas RNA interference-mediated knockdown of PPM1D inhibited proliferation, invasion, and migration of cultured HCC cells. In addition, PPM1D suppression by small interfering RNA decreased the tumorigenicity of HCC cells in vivo. Overall, results suggest that PPM1D is a potential prognostic marker and therapeutic target for HCC. 展开更多
关键词 ppm1d hepatocellular carcinoma PROGNOSIS target therapy
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部